HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A Weishaupt Selected Research

Antigens

7/2001Glucocorticosteroids modulate antigen-induced T cell apoptosis in experimental autoimmune neuritis and cause T cell proliferation in situ.
12/2000Molecular mechanisms of high-dose antigen therapy in experimental autoimmune encephalomyelitis: rapid induction of Th1-type cytokines and inducible nitric oxide synthase.
5/2000Role of TNF-alpha in high-dose antigen therapy in experimental autoimmune neuritis: inhibition of TNF-alpha by neutralizing antibodies reduces T-cell apoptosis and prevents liver necrosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


A Weishaupt Research Topics

Disease

4Experimental Autoimmune Neuritis
11/2001 - 05/2000
3Autoimmune Diseases of the Nervous System
07/2001 - 05/2000
2Guillain-Barre Syndrome
01/2007 - 03/2001
2Infections
01/2007 - 03/2001
2Dystonic Disorders (Writer's Cramp)
03/2001 - 06/2000
1Progressive Multifocal Leukoencephalopathy
08/2013
1Multiple Sclerosis
08/2013
1Stiff-Person Syndrome (Stiff Man Syndrome)
10/2009
1Diarrhea
03/2001
1Cytomegalovirus Infections (Inclusion Disease)
03/2001
1Torticollis (Wryneck)
03/2001
1Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
12/2000
1Autoimmune Diseases (Autoimmune Disease)
12/2000
1Dystonia (Limb Dystonia)
06/2000
1Necrosis
05/2000

Drug/Important Bio-Agent (IBA)

6Proteins (Proteins, Gene)FDA Link
10/2009 - 06/2000
3AntibodiesIBA
10/2009 - 03/2001
3AntigensIBA
07/2001 - 05/2000
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2001 - 05/2000
2Immunoglobulin G (IgG)IBA
08/2013 - 10/2009
2CopperIBA
03/2001 - 06/2000
2Messenger RNA (mRNA)IBA
03/2001 - 12/2000
2CytokinesIBA
12/2000 - 05/2000
1Natalizumab (Tysabri)FDA Link
08/2013
1Oligoclonal BandsIBA
08/2013
1anti-amphiphysin autoantibodyIBA
10/2009
1amphiphysinIBA
10/2009
1AutoantibodiesIBA
10/2009
1CalciumIBA
10/2009
1gamma-Aminobutyric Acid (GABA)IBA
10/2009
1GangliosidesIBA
01/2007
1Myelin P2 ProteinIBA
11/2001
1EpitopesIBA
11/2001
1AutoantigensIBA
11/2001
1Peptides (Polypeptides)IBA
11/2001
1T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA
11/2001
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
03/2001
1Immunologic Factors (Immunomodulators)IBA
03/2001
1Interleukin-2 Receptors (IL 2 Receptor)IBA
03/2001
1Cytokine Receptors (Cytokine Receptor)IBA
03/2001
1Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
03/2001
1SelectinsIBA
03/2001
1Immunoglobulins (Immunoglobulin)IBA
03/2001
1Interleukin-10 (Interleukin 10)IBA
12/2000
1Nitric Oxide Synthase (NO Synthase)IBA
12/2000
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
12/2000
1Ceruloplasmin (Ferroxidase)IBA
06/2000
1Neutralizing AntibodiesIBA
05/2000

Therapy/Procedure

4Therapeutics
08/2013 - 05/2000
1Punctures
08/2013
1Plasma Exchange
03/2001
1Immunotherapy
12/2000